Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab’s Place in COVID-19 Pneumonia

被引:0
|
作者
Timothée Klopfenstein
Vincent Gendrin
Aurélie Gerazime
Thierry Conrozier
Jean-Charles Balblanc
Pierre-Yves Royer
Anne Lohse
Chaouki Mezher
Lynda Toko
Cerise Guillochon
Julio Badie
Alix Pierron
N.’dri Juliette Kadiane-Oussou
Marc Puyraveau
Souheil Zayet
机构
[1] Nord Franche-Comté Hospital,Infectious Disease Department
[2] Jean-Minjoz University Hospital,Methodology Unit, Clinical Investigation Center INSERM 1431
[3] Nord Franche-Comté Hospital,Rheumatology Department
[4] Nord Franche-Comté Hospital,Intensive Care Unit Department
来源
关键词
Coronavirus disease 2019; Meta-analysis; Randomized clinical trial; Review; Tocilizumab;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1195 / 1213
页数:18
相关论文
共 50 条
  • [1] Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 Pneumonia
    Klopfenstein, Timothee
    Gendrin, Vincent
    Gerazime, Aurelie
    Conrozier, Thierry
    Balblanc, Jean-Charles
    Royer, Pierre-Yves
    Lohse, Anne
    Mezher, Chaouki
    Toko, Lynda
    Guillochon, Cerise
    Badie, Julio
    Pierron, Alix
    Kadiane-Oussou, N. 'dri Juliette
    Puyraveau, Marc
    Zayet, Souheil
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (03) : 1195 - 1213
  • [2] Tocilizumab in patients hospitalized with COVID-19 pneumonia: systematic review and meta-analysis of randomized controlled trials
    Gupta, Samiksha
    Padappayil, Rana Prathap
    Bansal, Agam
    Daouk, Salim
    Brown, Brent
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (01) : 55 - 60
  • [3] Tocilizumab for COVID-19: A systematic review and meta-analysis of randomized controlled trials
    Boppana, Tarun Krishna
    Mittal, Saurabh
    Madan, Karan
    Mohan, Anant
    Hadda, Vijay
    Guleria, Randeep
    MONALDI ARCHIVES FOR CHEST DISEASE, 2022, 92 (04)
  • [4] Effectiveness and safety of tocilizumab for COVID-19: a systematic review and meta-analysis of randomized clinical trials
    AlmeidaI, Paula Ribeiro Lopes
    PersonII, Osmar Clayton
    PugaIII, Maria Eduarda dos Santos
    GiustiIV, Maria Fernanda
    PintoV, Ana Carolina Pereira Nunes
    RochaVI, Aline Pereira
    AtallahVII, Alvaro Nagib
    SAO PAULO MEDICAL JOURNAL, 2023, 141 (02): : 168 - 176
  • [5] The effect of tocilizumab on COVID-19 patient mortality: A systematic review and meta-analysis of randomized controlled trials
    Lin, Wei-Ting
    Hung, Shun-Hsing
    Lai, Chih-Cheng
    Wang, Cheng-Yi
    Chen, Chao-Hsien
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 96
  • [6] Tocilizumab for severe COVID-19: a systematic review and meta-analysis
    Lan, Shao-Huan
    Lai, Chih-Cheng
    Huang, Hui-Ting
    Chang, Shen-Peng
    Lu, Li-Chin
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (03)
  • [7] Efficacy of tocilizumab in COVID-19: A systematic review and meta-analysis
    Aziz, Muhammad
    Haghbin, Hossein
    Abu Sitta, Emad
    Nawras, Yusuf
    Fatima, Rawish
    Sharma, Sachit
    Lee-Smith, Wade
    Duggan, Joan
    Kammeyer, Joel A.
    Hanrahan, Jennifer
    Assaly, Ragheb
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (03) : 1620 - 1630
  • [8] Enoxaparin for COVID-19: a systematic review and meta-analysis of randomized controlled trials
    Muhammad Ehsan
    Uzair Jafar
    Momina Butt
    Aiman Naveed
    Mohammad Umer
    Muhammad Ayyan
    Biah Mustafa
    Rehmat Ullah Awan
    Journal of Thrombosis and Thrombolysis, 2023, 56 : 495 - 498
  • [9] Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19
    Garcia-Albeniz, Xabier
    del Amo, Julia
    Polo, Rosa
    Morales-Asencio, Jose Miguel
    Hernan, Miguel A.
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2022, 37 (08) : 789 - 796
  • [10] Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19
    Xabier García-Albéniz
    Julia del Amo
    Rosa Polo
    José Miguel Morales-Asencio
    Miguel A Hernán
    European Journal of Epidemiology, 2022, 37 : 789 - 796